Chief Executive Officer
Tue, Jan 21, 2025
Jan 21
received an award in APLS
130,662 shares @ $0.00
Increased holdings by +43.40%
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology